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Soluble MHC-peptide (pMHC) complexes, commonly referred to as tetramers, are widely used to enumerate and to isolate
Ag-specific CD8 CTL. It has been noted that such complexes, as well as microsphere- or cell-associated pMHC molecules
compromise the functional integrity of CTL, e.g., by inducing apoptosis of CTL, which limits their usefulness for T cell sorting
or cloning. By testing well-defined soluble pMHC complexes containing linkers of different length and valence, we find that
complexes comprising short linkers (i.e., short pMHC-pMHC distances), but not those containing long linkers, induce rapid death
of CTL. This cell death relies on CTL activation, the coreceptor CD8 and cytoskeleton integrity, but is not dependent on death
receptors (i.e., Fas, TNFR1, and TRAILR2) or caspases. Within minutes of CTL exposure to pMHC complexes, reactive oxygen
species emerged and mitochondrial membrane depolarized, which is reminiscent of caspase-independent T cell death. The mor-
phological changes induced during this rapid CTL death are characteristic of programmed necrosis and not apoptosis. Thus,
soluble pMHC complexes containing long linkers are recommended to prevent T cell death, whereas those containing short linkers
can be used to eliminate Ag-specific CTL. The Journal of Immunology, 2005, 174: 6809–6819.
T he engagement of TCR and the coreceptor CD8 (or CD4)by peptide-MHC class I (pMHC)3 complexes expressedon other cells largely determines the development, differ-
entiation, and homeostasis of T cells (1). In the periphery, this
interaction primarily controls the activation and differentiation of T
lymphocytes. The studies of T cell activation also demonstrated
that TCR-pMHC interaction can lead to apoptosis of T cells to
maintain homeostasis (2). One form of such T cell deletion is
activation-induced cell death by Fas (CD95)-dependent mecha-
nisms (3). For mature CD8 T cells, TCR-induced apoptosis can
also be mediated by the TNFR (4). More recently activated T
cell-autonomous death (ACAD) has been described, which is Fas
ligand- and TNF--independent and primarily eliminates activated
T cells that express low levels of Bcl2 (5). An emerging consensus
is that activation-induced cell death mediates apoptosis of T cells
exposed to persistent Ags, such as autoantigens or pathogens caus-
ing chronic infections. Conversely, ACAD is thought to be mainly
responsible for the elimination of activated T cells during the con-
traction phase of strong immune response to transient stimuli, such
as viral infections (6). ACAD involves activation-induced gener-
ation of reactive oxygen species (ROS) and depolarization of mi-
tochondrial membranes (7). Decreased expression of antiapoptotic
molecules (e.g., Bcl-2) renders T cells susceptible for this mito-
chondrial dysfunction-dependent death (6).
Fluorescent-labeled soluble pMHC class I complexes, termed
tetramers or dimeric fusion proteins of pMHC with an Ig, are
widely used to enumerate and isolate Ag-specific CD8 T cells (8,
9). It has been noted that such reagents affect the functional integ-
rity of T cells (10–12), which is a concern when considering flu-
orescence-activated cell sorting or cloning of such cells. This is
especially true for activated effector CTL that are susceptible to
activation-dependent cell death as seen, for example, in the con-
traction phase after viral infection, when large numbers of antiviral
CTL are eliminated to re-establish homoeostasis (2). Although it is
known that soluble pMHC complexes can kill Ag-specific CTL, it
is not clear by what mechanism(s). So far, two mechanisms have
been described. First, cognate pMHC complexes expressed on tar-
get cells or microspheres (12) or as soluble pMHC complexes (10,
12) have been shown to induce Fas-dependent apoptosis of effector
CTL. Induction of CTL apoptosis does not require coengagement
of CD8 by pMHC, nor significant Lck activation, intracellular cal-
cium mobilization, or tyrosine phosphorylation (10, 12). It has
therefore been suggested that CD8 binding-deficient pMHC com-
plexes can be used to eliminate Ag-specific CTL in the absence of
systemic, potentially harmful CTL activation. Second, peptide can
be transferred from soluble to CTL-associated MHC molecules
and thus sensitize CTL for fratricide killing (13–15). Although the
mechanism of this peptide transfer remains to be elucidated, it is a
serious concern, especially when CTL are incubated for longer
periods of time with soluble pMHC complexes.
Soluble pMHC complexes, both of class I and class II, also have
been used as immunomodulatory agents. For example, dimeric
pMHC class II complexes have been shown to blunt autoreactive
T cell responses in animal models of diabetes type I and enceph-
alomyelitis (16–18). Dimeric pMHC class I complexes have been
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reported to inhibit CTL-mediated cytotoxicity in vivo (19, 20). The
underlying mechanism of this inhibition is not known, and because
it exhibited degenerate specificity, it may involve pMHC-induced
death of the CTL.
The present study was undertaken to investigate how soluble
pMHC complexes affect CTL viability. Such reagents are prepared
by reacting biotinylated pMHC monomers with PE- or allophyco-
cyanin-labeled streptavidin (8). Due to heterogeneities in these
streptavidin preparations, such reagents are ill-defined mixtures of
different pMHC complexes (10), hereafter referred to as multim-
ers. To prepare well-defined dimeric, tetrameric, and octameric
pMHC complexes, we used site-specific alkylation with linkers
containing spacers of different length, i.e., different pMHC-pMHC
distances (10, 21). For long spacers, we used polyprolines, which
in aqueous solution assume rigid proline II helixes, in which one
residue spans 3.1 Å (22). As cells, we used cloned S14 CTL and
CD8 T cells from T1 TCR transgenic mice, which recognize the
Plasmodium berghei circumsporozoite (PbCS) peptide 252–260
(SYIPSAEKI) containing photoreactive 4-azidobenzoic acid
(ABA) on K259 (PbCS(ABA)) in the context of Kd (23, 24). The
PbCS(ABA) variants containing alanine or leucine in place of pro-
line 255 are strong agonists for S14 and T1 CTL, respectively (25).
We report that pMHC complexes containing short, but not those
containing long linkers, induce rapid nonapoptotic death of CTL.
The new findings are discussed in the context of previously de-
scribed death mechanisms for T cells, and ways are shown how
appropriate pMHC complexes can be used either to eradicate Ag-
specific CTL or to avoid this.
Materials and Methods
Reagents, cells, and mice
All standard chemicals were purchased from Sigma-Aldrich, Merck, and
Alexis Biochemicals; tetramethylrhodamine methyl ester (TMRM), dihy-
droethidium (HE), dihydrorhodamine 123 (DHR), and 3,3-dihexyloxacar-
bocyanine iodide (DiOC6) were from Molecular Probes, and 7-aminoacti-
nomycin D (7AAD) and 1,4-diazabicyclo[2.2.2]octane (Dabco) were from
Sigma-Aldrich. MitoQ was a kind gift of Dr. M. Murphy (Medical Re-
search Council, Cambridge, U.K.). Cloned S14 CTL were cultured and
used as described (23–25). T1 TCR Tg mice (RAG-2/) were from Dr. E.
Palmer (University of Basel, Basel, Switzerland) (24) and handled accord-
ing to Swiss federal guidelines. Effector T1 T cells were obtained by in-
jecting T1 TCR Tg mice i.v. with 50 nmol of PbCS(ABA) peptide 2 days
before harvesting their splenocytes, which were cultured in IL-2 (30 U/ml)-
containing medium for another 4–7 days. “Naive T cells” refers to spleno-
cytes from nonprimed T1 TCR Tg mice. Anti-actin rabbit polyclonal Ab
was from Sigma-Aldrich, anti-cytochrome oxidase (COX) subunit IV mAb
(20E8) was from Molecular Probes, and anti-cytochrome c (7H8.2C12) was
from Apotech. The soluble death receptor-Fc fusion proteins (Fas-Fc,
TRAILR2-Fc, and TNFR1-Fc) were produced and used as described (26, 27).
Preparation of soluble Kd-peptide molecules
Monomeric Kd-PbCS(ABA) complexes, and its mutant KdD227K-PbC-
S(ABA) (charge inversion in position 227), containing either a C-termi-
nally added BirA substrate peptide or a free cysteine in position 275 were
prepared by refolding of H chain and human 2-microglobulin in the pres-
ence of peptide as described (10). As peptides, either the wild-type PbC-
S(ABA) (SYIPSAEK(ABA)I), PbCS(ABA)P255A (SYIASAEK(ABA)I),
which is a strong agonist for S14 CTL, PbCS(ABA)P255L (SYILSAEK-
(ABA)I), which is a strong agonist for T1 CTL (25), or the irrelevant Cw3
170–179 peptide (RYLKNGKETL) were used. The linkers used for the
preparation of the pMHC complexes were as follows: for diaminopropionic
acid (Dap)S dimer, maleimidoacetoxy-S-Dap(S-maleimidoacetoxy)-Y-
D-K(Cy5)-P (I); for P30 dimer, Cy5-Dap(maleimidoacetoxy)-P30-Dap
(maleimidoacetoxy)-P (II); for PEO tetramer, biotinyl-iodoacetamidyl-3,6-
dioxaoctanediamine (Pierce Biotechnology); for P24 tetramer, biotin-Y-
P24-Dap(maleimidoacetoxy biotin)-P (III); and for DapS/P10 octamer, ma-
leimidoacetoxy-S-Dap(S-maleimidoacetoxy)-Y-P10-K(biotin)-P (IV). All
linkers were synthesized on solid phase using proline-2-chlorotrityl resin
(Novabiochem), Fmoc for transient protection, and very acid labile orthog-
onal protection groups. Biotin was introduced by using Fmoc-K(biotin)
(Bachem). Sequential couplings were performed with 2.5 M excess of the
respective amino acids and monitored with the chloranil color test. After
each coupling, end-capping was performed with a 20-fold molar excess of
acetic anhydride and di-isoprolyethylamine. For I and IV, the last coupling
reaction was with N-(-maleimidoacetoxy)succinimide ester (Pierce) in
dimethylformamide/2,4,6-collidine 1/0.01 (v/v) for 4 h at room tempera-
ture; for II, with Cy5-hydroxysuccinimide ester in dimethylformamide/
DMSO/di-isopropylethyamine 1/0.1/0.01 (v/v/v) for 12 h at room temper-
ature; and for III, likewise with biotin hydroxysuccinimide ester. Peptides
were cleaved from the resin with 5% trifluoroacetic acid in dichlorometh-
ane containing 5% tri-isopropylsilane and purified on a semipreparative C4
column (Vydac), which was eluted with a linear gradient of CH3CN rising
from 0 to 75% in 60 min at a flow rate of 4 ml/min. The purified peptides
were characterized by mass spectrometry on a Voyager DE MALDI-TOF
mass spectrometer (Applied Biosystems). For I, the purified peptide was
then reacted at the free amino group with a 2-fold molar excess of Cy5
hydroxysuccinimide esters, and for II and III, with a 10-fold molar excess
of N-(-maleimidoacetoxy)succinimide ester. The products were purified
by precipitation with ether, by gel filtration on Superdex Peptide column
(Amersham Biosciences), and by chromatography on a C4 reverse-phase
HPLC column, and characterized by mass spectrometry.
Dimeric, tetrameric, octameric, and multimeric Kd-peptide complexes
were prepared by site-specific alkylation as described (10, 21). In brief, the
complexes were reduced with 15 mM glutathione and reacted with a 10-
fold molar excess of the respective maleimide linkers or with Cy5-male-
imide (Amersham Biosciences) for 2 h at room temperature under argon.
The alkylated Kd-PbCS(ABA) complexes were purified by gel filtration on
a Superdex S75 column. Dimeric Kd-PbCS(ABA) complexes were ob-
tained by reacting the monomeric complexes with a 2-fold molar excess of
reduced Kd-PbCS(ABA)-Cys and purified by gel filtration on Superdex
S200 column (10). Tetrameric and octameric pMHC complexes were ob-
tained by reacting biotinylated mono- and dimeric pMHC complexes with
a 4-fold molar excess with Cy5-labeled streptavidin (Amersham Bio-
sciences) and purified by gel filtration on a Superdex 200 column. Multi-
meric complexes were obtained by reacting biotinylated Kd-PbCS(ABA)
monomers with PE streptavidin (Caltag) as described (10).
Binding assay
For binding measurements, S14 CTL (5  105) were incubated for 5 min
at 37°C with graded concentrations of Cy5-labeled pMHC complexes in 50
l of FACS buffer (OptiMEM; Invitrogen Life Technologies) supple-
mented with 1% (w/v) BSA (fraction V; Sigma-Aldrich), 15 mM HEPES,
10 mM EDTA, and 0.02% (w/v) sodium azide. After UV irradiation (at
4°C for 30–40 s with 90-W mercury fluorescence light of 312  40 nm),
the cells were washed twice in cold FACS buffer, and cell-associated flu-
orescence was measured on a FACSCalibur flow cytometer (BD
Biosciences).
Calcium mobilization and cytotoxic assay
Intracellular calcium levels were measured by flow cytometry using the
calcium sensitive dye Indo-1 and as described (28). For cytotoxicity anal-
ysis, 51Cr-labeled P815 cells (5  103 cell/well) were incubated in micro-
titer plates containing 10-fold dilutions of SYIPSAEK(ABA)I peptide in
DMEM supplemented with 5% FCS and 10 mM HEPES. S14 CTL (1.5 
104 cells/well) were added after 5 min and after 4 h of incubation at 37°C,
the released chromium was measured in supernatants. The specific lysis in
percentage was calculated as follows: (experimental release spontaneous
release/total release  spontaneous release)  100. The total release of
51Cr was measured upon lysis of the target cells in 1% SDS. For inhibition
assay, S14 CTL were preincubated with pMHC complexes for 30 min at
37°C before addition of the target cells. For bystander killing assay, un-
sensitized target cells were used, and CTL were pretreated or not with 20
M brefeldin A for 2 h at 37°C.
Cell death and DNA fragmentation assays
S14 CTL or T1 T cells (1  105), preincubated with 20 M brefeldin A (2
h, 37°C), were incubated with pMHC complexes for different periods of
time at 37°C, washed with PBS, stained with Cy5- or FITC-labeled an-
nexin V and 7AAD according to the manufacturer’s recommendations (BD
Biosciences) and analyzed by flow cytometry. Of note, Cy5-labeled an-
nexin V detects externalized phosphatidylserine (PS) with higher sensitiv-
ity than FITC labeled. The data were analyzed by CellQuest software (BD
Biosciences). Debris was excluded on the basis of forward and side scat-
tering and dead cells by gating out 7AAD-positive counts. DNA fragmen-
tation was analyzed using the In situ Cell Death Detection kit according to
the manufacturer’s recommendations (Roche).
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Assessment of mitochondrial membrane potential (m)
and ROS
The fluorescent probes TMRM and DiOC6 were used to measure m loss.
S14 CTL or effector T1 T cells (1  105), preincubated with 20 M
brefeldin A for 2 h at 37°C, were incubated or not with pMHC complexes,
and were then incubated with 100 nM TMRM or 40 nM DiOC6 together
with 2 g/ml 7AAD for 30 min at 37°C, and the m-dependent fluores-
cence was measured by flow cytometry (LSR; BD Biosciences) in the
7AAD-negative population. For ROS measurements, the same procedure
was used except that ROS-sensitive probes, 10 M DHR or 5 M HE,
were used. Data were processed using CellQuest software.
Cell fractionation and cytochrome c release analysis
S14 CTL (1  106 cells), untreated or upon incubation with pMHC com-
plexes, were washed in PBS (two times) and lysed on ice in 100 l of
digitonin lysis buffer (75 mM NaCl, 1 mM NaH2PO4, 8 mM Na2HPO4
containing 190 g/ml digitonin and Roche’s complete protease inhibitors).
Samples were centrifuged at 13,000 rpm for 10 min. Supernatant (cytosolic
fraction) was kept, and the pellet was lysed in OG lysis buffer (20 mM
Tris-HCl, pH 8.2, containing 100 mM NaCl, 10 mM EDTA, 1% octyl
-D-glucopyranoside, and Roche’s protease inhibitor mixture) for 30 min
on ice. The nuclei were spun out at 3000  g for 3 min. The postnuclear
supernatants (membrane fraction) and cytosolic fractions were resolved on
SDS-PAGE (10% reducing) and analyzed by Western blotting using Abs
specific for cytochrome c, COX subunit IV (COX IV) (mitochondria
marker), and actin (loading control), respectively.
Microscopic analyses
For all microscopic analyses, S14 CTL, pretreated with 20 M brefeldin A,
were incubated in DMEM supplemented with 2 g/ml 2-microglobulin in
the absence or presence of 12.5 nM Kd-PbCS(ABA)P255A DapS dimer for
different periods of time. The samples were analyzed by DC200 light mi-
croscope (Leica), and the images were processed using Photoshop 5.0 soft-
ware (Adobe). Confocal microscopy was conducted on a LSM510 confocal
microscope (Zeiss). S14 CTL were incubated with 12.5 nM DapS dimer for
different periods of time at 37°C. After fixation with 3% paraformaldehyde
and staining with Alexa 488-labeled cholera toxin subunit B, the cells were
mounted in PBS containing 50% (v/v) glycerol and 0.2 M Dabco, and
analyzed by confocal microscopy. Three-dimensional reconstruction was
performed using Imaris software (Bitplane). For electron microscopy, S14
CTL (2  107 cells) in OptiMEM containing 10 mM PbCS peptide and 2
g/ml human 2-microglobulin were incubated in the absence or presence
of 12.5 nM DapS dimer for 15 min at 37°C. After washing, cells were fixed
in 2.5% glutaraldehyde in PBS, postfixed in 1% OsO4, dehydrated in eth-
anol and propylenoxide, and embedded in Durcupan/Epon mixture. Eighty-
nanometer sections were contrasted with uranyl acetate and lead citrate
according to Reynolds and analyzed on a Morgagni transmission electron
microscope operated at 80 kV (FEI) equipped with MegaView III digital
camera (SIS).
Results
Soluble pMHC complexes inhibit CTL-mediated cytotoxicity by
killing the CTL
Based on previous reports indicating that soluble dimeric and mul-
timeric pMHC complexes inhibit CTL-mediated cytotoxicity (19,
20), we assessed the ability of Kd-PbCS(ABA)P255A DapS dimer
and multimers to inhibit the lysis of PbCS(ABA)-sensitized P815
cells by cloned S14 CTL. As shown in Fig. 1, both complexes
strongly inhibited target cell killing, especially at submaximal pep-
tide concentrations.
To ascertain whether this inhibition was caused by pMHC-me-
diated death of the CTL, we performed flow cytometric analysis of
cloned S14 CTL before and after 30-min exposure to soluble
pMHC complexes. Cell debris were gated out based on forward-
and side-scatter profiles (Fig. 2). The cells were stained with an-
nexin V, which binds to externalized PS on dying cells, and
7AAD, which labels dead cells (i.e., cells with permeabilized
membranes). After incubation of CTL with Kd-PbCS(ABA) mul-
timers, the annexin V staining increased 4.4-fold compared with
untreated cells or cells incubated with noncognate Kd-Cw3 170–
179 multimers (Fig. 2 and data not shown). Essentially, the same
results were obtained when Kd-PbCS(ABA)P255A multimers
were used, indicating that complexes containing the wild-type ag-
onist (PbCS(ABA)) or the strong agonist (PbCS(ABA)P255A)
were equally active. When cells were incubated with Kd-
PbCS(ABA)P255A DapS dimer, 50% of the cells were annexin
V positive. The fraction of 7AAD-positive cells increased in par-
allel with the annexin V-positive cells. After 30 min of incubation,
this increase was3-fold, but then rapidly increased with the time
of incubation (Fig. 2 and data not shown). Taken collectively,
these results indicate that DapS dimer and multimers inhibit S14
CTL-mediated cytotoxicity by killing the CTL.
Soluble pMHC complexes containing short linkers cause rapid
death of cloned S14 CTL
To extend the finding that pMHC dimers and multimers kill S14
CTL (Fig. 2), we tested additional well-defined soluble Kd-
PbCS(ABA)P255A complexes (Table I) for their ability to induce
PS externalization. After 30 min of incubation with the short DapS
dimer, 50% of S14 CTL were annexin V positive, but upon
FIGURE 2. pMHC dimers and multimers rapidly induce PS external-
ization on cloned S14 CTL. S14 CTL were incubated at 37°C for 30 min
in the absence (Untreated) or presence of 2 nM Kd multimers containing
the wild-type PbCS(ABA) peptide, the strong agonist variant PbCS(ABA)
P255A, or Kd-PbCS(ABA)P255A DapS dimer. Externalization of PS
(dying cells) and membrane permeabilization (dead cells) were enumerated
by staining with annexin V and 7AAD, respectively, and flow cytometry.
Numbers indicate the fraction of cells in the given quadrants. One repre-
sentative experiment of three is shown. FSC, Forward scatter; SSC, side
scatter.
FIGURE 1. Soluble pMHC complexes inhibit target cell killing by S14
CTL. S14 CTL were incubated at 37°C for 30 min in the absence () or
presence of indicated concentrations of Kd-PbCS(ABA)P255A DapS
dimer (f) or multimers (u), and then added to 51Cr-labeled P815 cells
(E:T  3:1) with 10 nM PbCS(ABA) peptide, and a standard cytotoxic
assay was performed. The specific lysis was calculated from released chro-
mium. Mean values and SD were calculated from three experiments.
6811The Journal of Immunology
incubation with the long P30 dimer, only 15% were (Fig. 3A).
Following incubation with the PEO tetramer, approximately one-
third of the cells externalized PS, i.e., slightly more compared with
multimers. Conversely, the multimer containing the charge inver-
sion D227K, which strongly reduces coengagement of CD8, in-
duced only modest PS externalization, even though its binding to
S14 CTL was only slightly reduced (Fig. 3, A and D). Upon in-
cubation with DapS/P10 octamer, nearly one-half of the cells were
annexin V positive. In all cases, no higher values were observed
when higher pMHC concentrations were used (data not shown).
The PS externalization on S14 CTL increased with the concen-
tration of the DapS dimer, reaching a maximum at 12.5–25 nM.
The increase in intracellular calcium induced by DapS dimer ex-
hibited essentially the same concentration dependence as the PS
externalization (Fig. 3B). The same was true for the other pMHC
complexes tested (data not shown). The pMHC concentrations giv-
ing maximal calcium mobilization and PS externalization were
significantly lower than the concentrations giving maximal pMHC
binding (Fig. 3, D–F). This difference was especially striking for
the larger complexes (octamer 	 multimer 	 tetramer). Thus, the
relatively small differences in binding between the long and short
dimers and tetramers, and wild-type and D227K multimers, re-
spectively, do not account for the observed large differences in
biological activity. These experiments also show that the binding
of the noncognate pMHC complexes to S14 CTL is very low;
therefore, noncognate pMHC binding to CD8 is irrelevant for CTL
activation in this system. The good temporal and dose-dependent
correlation between PS externalization and CTL activation argues
that these two processes are linked. In agreement with this, we
found that monomers were unable to elicit PS externalization and
equally failed to activate S14 CTL (Fig. 3C and Ref. 29). This also
shows that peptide transfer from soluble to cell-associated pMHC
molecules (13, 14) does not account for the observed effects.
The PS externalization induced by DapS dimer was rapid, reach-
ing a maximum after 30 min of incubation (Fig. 3C). However, this
is likely to be an underestimate, because the number of dead cells
(7AAD positive) increases with time and hence are not monitored
in our flow cytometric assay (Fig. 2). To test this directly, we
examined S14 CTL after different periods of incubation with DapS
dimer by transmission and confocal microscopy. In a matter of a
few minutes, the cells typically rounded up, and pronounced bleb
formation and ballooning were observed (Fig. 4A). Already after
10 min, cells were damaged irreversibly, showing that PS exter-
nalization assessed by annexin V staining indeed reflects cell
death. Also, S14 CTL rapidly exhibited strong clustering upon
incubation with DapS dimer, which is typical for dying cells (Fig.
4B). The number of living cells steadily decreased over time, and
after 1 h of incubation, cell debris and dead cells were abundant.
Mechanism of DapS dimer-induced death of S14 CTL
Because the previously described apoptosis of CTL by Fas-depen-
dent mechanisms or fratricide typically occur with a slower kinet-
ics than the rapid death observed here (Figs. 2 and 4; Refs. 10 and
12), we further explored the underlying mechanism. To this end,
we tested the effects of inhibitors for perforin (concanamycin A),
granzymes (zAADcmk), or caspases (zVADfmk) on DapS dimer-
induced death of S14 CTL. None of these inhibitors had any effect
(Fig. 5A), although, as expected, they inhibited to different degrees
the lysis of sensitized target cells (B). Similar results were obtained
for PEO tetramer and DapS/P10 octamer (data not shown).
Table I. The pMHC complexes under study
pMHC Complexes Linkers
Maximal
Distance (Å)
Dimers DapS Mal™Dap™(Sa™Mal)™YDK (Cy5)™P 17.8 (x1)
P30 Cy5™Dap (Mal)™P30™Dap (Mal)™P 117 (x1)
Tetramers PEO I™CH2CO™NH™(PEO)™(CH2)2™NH2™biotin 25 (x2)
P24 Biotin™Y™P24™K (Mal)™P 88 (x2)
Octamer DapS/P10 Mal™S
Mal™S	Dap™Y™P10™K (biot)™P
17.8/45 (x3/x4)
a Single-letter amino acid code is used.
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Testing of additional inhibitors showed that the DapS dimer-
induced death of S14 CTL was inhibited by agents that impede
CTL activation, such as inhibitors for protein kinase C (PKC), PI3K,
MAPK and Src kinases, the cation chelator EDTA, and the actin
polymerization inhibitor latrunculin A (Table II). By contrast, block-
ing of CD28, CTLA-4, or protein synthesis had no effect.
We next investigated whether DapS dimer triggers S14 CTL for
bystander cell killing. Significant lysis of unsensitized P815 cells
was observed only at high concentrations of DapS dimer and only
in the absence of brefeldin A (Fig. 5C). Brefeldin A blocks the
transfer of exogenous peptides to cell-associated MHC molecules
and has no effect on target cell killing, arguing that this bystander
cell killing is accounted for by transfer of peptide from soluble to
cell-associated MHC molecules (Refs. 13, 14, and 30, and data not
shown). To prevent such peptide transfer and thus to rule out frat-
ricide of CTL, brefeldin A was included in all experiments. Fi-
nally, the DapS dimer-induced death of S14 CTL was not affected
by the soluble death receptors Fas, TNFR1, and TRAILR2, which
in control experiments completely inhibited Fas ligand-, TNF--,
and TRAIL-mediated cytotoxicity (Fig. 5D; Refs. 26 and 27; data
not shown). Taken together, these results indicate that pMHC-in-
duced death of S14 CTL requires full CTL activation, but is not
mediated by perforin/granzymes, fratricide, nor classical death
receptors.
FIGURE 3. S14 CTL rapidly externalize PS after the activation with various soluble pMHC molecules. A, S14 CTL were incubated with Kd-
PbCS(ABA)P255A DapS dimer (12.5 nM), P30 dimer (12.5 nM), PEO tetramer (5 nM), DapS/P10 octamer (1 nM), multimers (2 nM), or KdD227K-
PbCS(ABA)P255A multimers (4 nM) for 30 min at 37°C, and the percentage of annexin V-positive and 7AAD-negative cells was assessed by flow
cytometry. The control (C) refers to untreated S14 CTL. SD were calculated from two independent experiments. B, S14 CTL were incubated likewise with
the indicated concentrations of DapS dimer, and the percentage of annexin V-positive cells was assessed by flow cytometry (u). Alternatively, Indo-1-
labeled S14 CTL were incubated with the same concentration of DapS dimer and calcium-dependent Indo-1 fluorescence was measured by flow cytometry
over 3 min. f, The maximal calcium responses. One representative of three experiments is shown. C, S14 CTL were incubated at 37°C for the indicated
periods of time with monomer (200 nM) or DapS dimer (12.5 nM), and the percentage of annexin V-positive cells was assessed by flow cytometry. The
control (C) refers to untreated S14 CTL. Mean values and SD were calculated from three experiments. D–F, S14 CTL were incubated at 37°C for 5 min
with graded concentrations of the following: D, PE-labeled multimers containing the Kd-PbCS(ABA) (), Kd-PbCS(ABA)P255A (dashed line; ‚),
KdD227K-PbCS(ABA) (f), or Kd-Cw3 (170–179) (); E, Cy5-labeled Kd-PbCS(ABA)P255A P24 tetramer (), PEO tetramer (f), DapS/P10 octamer (F),
or DapS/P10 octamer containing the Cw3 peptide 170–179 (); or F, Cy5-labeled Kd-PbCS(ABA)P255A monomer (), DapS dimer (f), P30 dimer (Œ),
or DapS dimer containing the Cw3 170–179 peptide (), and cell-associated fluorescence was measured by flow cytometry after UV irradiation and
washing. Mean values and SD were calculated from two to four experiments. Of note, the molar fluorescent intensities are the same for the multimers, the
tetramers and octamers, and the monomer and dimers, respectively.
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Soluble pMHC complexes trigger depolarization of
mitochondrial membranes and production of ROS
To assess whether pMHC complex-induced cell death relies on
mitochondrial dysfunction, we examined what effect different Kd-
PbCS(ABA)P255A complexes have on m on S14 CTL. To this
end, the cells were incubated with pMHC complexes and TMRM,
which binds to polarized, but not depolarized, mitochondrial mem-
branes (31). S14 CTL upon incubation with short DapS dimer and
DapS/P10 octamer exhibited substantially less TMRM fluores-
cence compared with untreated cells (Fig. 6A). CTL incubated
with monomeric or long P30 dimeric complexes exhibited only
slightly reduced TMRM fluorescence. Thus, in accordance with
the annexin V staining, the short pMHC complexes caused loss of
the m, which is a hallmark of mitochondrial dysfunction-medi-
ated death (32). Essentially the same results were obtained when
using DiOC6, another sensitive dye (Ref. 33 and data not shown).
When the CTL were incubated instead with DHR, which ac-
quires fluorescence in the presence of ROS (34), the opposite sit-
uation was observed. Cells incubated with the short dimeric and
octameric complexes exhibited strong DHR fluorescence com-
pared with untreated cells or cells incubated with monomeric or
long P30 dimeric complexes (Fig. 6B). Essentially, the same
FIGURE 5. DapS dimer-induced death of S14 CTL does not rely on classical cell death pathways. A, S14 CTL untreated or preincubated with inhibitors
for perforin (concanamycin A; CMA), granzymes (zAAD-cmk), or caspases (zVAD-fmk) were incubated at 37°C for 30 min with Kd-PbCS(ABA)P255A
DapS dimer (12.5 nM), and the percentage of annexin V-positive cells was assessed by flow cytometry. B, S14 CTL pretreated likewise were incubated
for 4 h at 37°C with 51Cr-labeled P815 cells (E:T  3:1) previously pulsed with PbCS(ABA) peptide (1 nM). Specific lysis was calculated from released
chromium. Mean values and SD were calculated from three experiments. C, S14 CTL, untreated () or treated with 20 M brefeldin A (f), were incubated
with 51Cr-labeled P815 cells, and specific lysis was assessed as described for B. D, S14 CTL were incubated with DapS dimer (12.5 nM) together with
the indicated soluble death receptors (50 g/ml) for 30 min at 37°C, and the percentage of annexin V cells was assessed by flow cytometry. Mean values
and SD were calculated from two experiments.
FIGURE 4. S14 CTL incubated with DapS dimer
exhibit strong bleb formation, ballooning, and cell
death. A, S14 CTL were incubated with Kd-
PbCS(ABA)P255A DapS dimer (12.5 nM) at 37°C for
the indicated period of time and, after fixation, analyzed
by confocal microscopy. B, Alternatively, incubations
were assessed by transmission light microscopy after
the indicated periods of time. Representative experi-
ments of three are shown.
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results were obtained when using hydroethidium, another ROS-
sensitive dye (Ref. 33 and data not shown). These results indi-
cate that soluble pMHC complexes, which cause the death of
S14 CTL, also induce depolarization of mitochondrial mem-
branes and generation of ROS. This is in accordance with stud-
ies showing that depolarization of mitochondrial membranes
and generation of ROS leads to mitochondrial dysfunction and
T cell death (5, 32).
Antioxidants and cyclosporin A inhibit pMHC-induced
CTL death
Because of the known relationship between ROS generation and
mitochondrial dysfunction (32), we tested several antioxidants
known to inhibit ROS production. MitoQ, a mitochondria-targeted
antioxidant (35), completely inhibited the DapS dimer-induced
death of S14 CTL (Fig. 7A). In addition, vitamin C strongly in-
hibited S14 CTL PS externalization, whereas ebselen only mod-
erately. At the concentrations used, these antioxidants were not
toxic and had no effect on the intracellular calcium mobilization
induced by DapS dimer (Fig. 7B). For MitoQ, calcium mea-
surements were not performed, because its fluorescence over-
laps with that of Indo-1. The superoxide dismutase mimetic,
Mn(III)tetrakis(5,10,15,20-benzoic acid)porphyrin (200 M
MnTBAP), also inhibited DapS dimer-induced PS externaliza-
tion; however, at the concentrations required, it also inhibited
calcium mobilization and tyrosine phosphorylation (data not
shown). Cyclosporin A completely inhibited PS externalization,
FIGURE 6. DapS dimer induces mitochondrial membrane depolarization
and ROS production in S14 CTL. A, S14 CTL were incubated for 30 min at
37°C with Kd-PbCS(ABA)P255A monomer (200 nM), DapS dimer (12.5
nM), P30 dimer (12.5 nM), or DapS/P10 octamer (1 nM), and the m-de-
pendent dye TMRM, and analyzed by flow cytometry. Bars represent the
percentage of cells with depolarized mitochondria. The inset demonstrates a
representative histogram of untreated (filled) and DapS dimer-treated (bold
line) cells and the gate used for evaluation. B, S14 CTL were labeled with the
ROS-sensitive dye DHR, treated with the different pMHC complexes as de-
scribed for A, and ROS-dependent increase of DHR fluorescence was mea-
sured by flow cytometry. Bars represent the percentage of cells with increased
ROS. The inset shows a representative histogram of untreated (filled), respec-
tively DapS dimer-treated (bold line) S14 CTL, and the gate used for evalu-
ation. Mean values and SD were calculated from three experiments.
FIGURE 7. Inhibitory effect of antioxidants and cyclosporin A on sol-
uble pMHC-induced S14 CTL death. A, S14 CTL, untreated or pretreated
with cyclosporin A (25 M) and the antioxidants ebselen (20 M), vitamin
C (1 mg/ml), or MitoQ (1 M), respectively, were incubated at 37°C for
30 min with Kd-PbCS(ABA)P255A DapS dimer (12.5 nM), and the per-
centage of annexin V-positive cells was assessed by flow cytometry. Mean
values and SD were calculated from two experiments. B, S14 CTL, un-
treated (‚) or pretreated with ebselen (E), vitamin C () and cyclosporin
A (), respectively, were labeled with Indo-1, and its calcium-dependent
fluorescence was analyzed for 3 min after stimulation with 12.5 nM DapS
dimers. Untreated and unstimulated cells (f) were used as control. The
arrow indicates the addition of DapS dimer.
Table II. The effect of inhibitors on death of S14 CTL induced by 12.5
nM DapS dimer for 30 min at 37°Ca
Ab/Inhibitor/Agent Affected/Inhibited Process
Inhibition of PS
Externalization
Anti-CD28 Ab Costimulation 
Anti-CTLA-4 Ab Costimulation 
Concanamycin A Perforin killing 
zVADfmk Pan-caspase 
zAADcmk Granzymes 
zDEVDfmk Caspase-3 specific 
E64d Cathepsin B and L 
PP2 Src family kinases 
Latrunculin A Actin polymerization 
Wortmanin PI3K 
Rottlerin Classical PKC 
Go¨6976 Nonclassical PKC 
SB202192 p38 MAPK 
Cycloheximide De novo protein synthesis 
Natrium azide ABC transporter inhibitor 
EDTA Chelating agent 
a Key: , 0–5%; , 30–50%; , 50–80%; , 80–100%. The in-
hibitors that negatively regulate signaling induced by TCR/CD8 coengagement are
indicated in bold.
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but moderately also inhibited the DapS dimer-induced calcium
mobilization.
Soluble pMHC complexes induce necrosis rather than apoptosis
of S14 CTL
A hallmark of Fas-mediated apoptosis of T cells is DNA fragmen-
tation and release of cytochrome c from mitochondria into the
cytosol. As assessed by the TUNEL assay, S14 CTL exhibited
only modest DNA fragmentation upon incubation with DapS
dimer in the assayed 30-min period (Fig. 8A). After 30 min of
incubation, no cytochrome c was detectable in the cytosol (Fig.
8B). The conclusion that therefore DapS dimer-induced death of
S14 CTL is not apoptosis is supported by electron microscopy. S14
CTL incubated with DapS dimer exhibited nonapoptotic nuclei
(dispersed foci of chromatin and heterochromatin), nonhomoge-
neous cytoplasmic pattern, rounded mitochondria with disrupted
internal structures, and extensive vacuolization compared with the
untreated cells (Fig. 9). In particular, the vacuolation of the cyto-
plasm, rounding of mitochondria, and disruption of their internal
structures are characteristic for programmed necrosis but not for
apoptosis (36).
Short but not long pMHC complexes efficiently kill effector but
not naive CD8 T1 T cells
To determine the general relevance of the findings obtained using
cloned S14 CTL, we examined T cells from primed T1 TCR trans-
genic mice. To this end, effector T1 T cells were incubated with
Kd-PbCS(ABA)P255L monomer, DapS and P30 dimers, PEO and
P24 tetramers, or DapS/P10 octamer, and PS externalization was
analyzed by flow cytometry. In good agreement with the results
obtained on S14 CTL, DapS dimer, PEO tetramer, and DapS/P10
octamer induced extensive PS externalization (Fig. 10A). By con-
trast, the monomer as well as the long P30 dimer and P24 tetramer
gave only modest or background levels. No higher values were
observed when higher pMHC concentrations were used.
Effector T1 T cells, upon incubation with DapS dimer and
DapS/P10 octamer, exhibited much stronger annexin V staining
FIGURE 9. DapS dimer induces morphological changes in S14 CTL con-
sistent with programmed necrosis. S14 CTL untreated (A and B) or upon
incubation with Kd-PbCS(ABA)P255A DapS dimer for 15 min at 37°C (12.5
nM) (C–F) were fixed and analyzed by transmission electron microscopy.
Unlike untreated cells, CTL incubated with DapS dimer exhibited depletion of
chromatin density and chromatin clumping (C and D), appearance of multiple
dense large telolysosomes (TL), dilated endoplasmic reticulum (arrow 1) and
Golgi apparatus (arrow 2), altered mitochondria (M) of irregular and dilated
shape (E) or with condensed matrix (F). Bars represent 1 m.
FIGURE 10. Primed T1 T cells are more susceptible to soluble pMHC-
induced death than naive cells. A, Effector T cells from T1 TCR Tg RAG-
2/ mice were incubated at 37°C for 30 min with Kd-PbCS(ABA)P255L
monomer (100 nM), DapS dimer (12.5 nM), P30 dimer (12.5 nM), PEO
tetramer (5 nM), P24 tetramer (5 nM), or DapS/P10 octamer (1 nM), and
the percentage of Cy5-labeled annexin V-positive cells was analyzed by
flow cytometry. B, Naive (u) and effector (f) T1 T cells were incubated
likewise with monomer (100 nM), DapS dimer (12.5 nM), or DapS/P10
octamer (1 nM), and the percentage of FITC-labeled annexin V-positive
cells was determined by flow cytometry. C, Indo-1-labeled naive (u) and
effector (f) T1 T cells were incubated at 37°C with monomers (100 nM),
DapS dimer (12.5 nM), or DapS/P10 octamer (1 nM), and calcium-depen-
dent fluorescence was analyzed by flow cytometry for 3 min. Maximal
calcium responses are shown. Mean values and SD were calculated from
three experiments.
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compared with naive T1 T cells (Fig. 10B). By contrast, the cal-
cium responses induced by these complexes were similar on naive
and activated T1 T cells (Fig. 10C), arguing that the resistance of
the naive T1 T cells to undergo pMHC complex-induced death is
not explained by lack of cell activation. As on S14 CTL, the con-
centrations giving maximal biological activity were significantly
below those giving maximal binding (data not shown). Taken to-
gether, these findings indicate that effector, but not naive T1 T
cells, like cloned S14 CTL, are susceptible to pMHC complex-
induced, activation-dependent death. By examining the suscepti-
bility of T1 T cells to undergo pMHC-induced death at different
stages of differentiation, we found that it correlates with their ac-
quisition of cytotoxicity (data not shown).
Discussion
The key finding of the present study is that activated effector CTL
undergo rapid cell death upon exposure to soluble pMHC com-
plexes. The cell death described here is clearly different from the
previously described pMHC-induced apoptosis of CTL (10, 12).
First, it occurs with a much faster kinetics. Although Fas-depen-
dent death of CTL was extensive only after several hours of in-
cubation with pMHC, the death described here is induced within a
few minutes (12, 37). This does not exclude that CTL that resist
the rapid pMHC-induced death described here succumb at a later
time to Fas-dependent apoptosis. It is important to note, however,
that upon prolonged incubation of CTL with soluble pMHC com-
plexes, transfer of peptide from soluble to cell-associated MHC
molecules does occur (13, 14). Although we show here that brefel-
din A impedes this peptide transfer, mainly by inhibiting loading
of newly synthesized MHC molecules (30), this inhibition is ef-
fective only for a limited time (Fig. 5C and our unpublished
results).
Second, the CTL death described here requires CD8 coengage-
ment and full CTL activation, whereas Fas-dependent CTL death
can occur without CD8 coengagement and extensive CTL activa-
tion (12). Third, although binding of death ligands to their respec-
tive death receptors, Fas, TNFR1, and TRAILR2, as well as acti-
vation of caspases play a crucial role in T cell apoptosis (38), none
of this was observed for the pMHC-induced CTL death described
here (Fig. 5). Fourth, a hallmark of classical apoptosis is cyto-
chrome release from mitochondria into the cytosol, DNA fragmen-
tation, and strong chromatin condensation (15, 36, 38). Neither
cytochrome c release nor marked DNA fragmentation and chro-
matin condensation were observed in DapS dimer-treated S14
CTL (Figs. 8 and 9). Instead, CTL incubated with DapS dimer
exhibited inhomogeneous cytoplasmic pattern with strong vacuol-
ization, rounded mitochondria with disrupted internal structures,
which are characteristic for programmed necrosis (36, 38). The
rapid formation of blebs and ballooning observed on pMHC-
pulsed CTL together with extensive vacuolization of the cytoplasm
are also typical for autophagy (36, 39), indicating that the pMHC-
induced CTL death harbors features both of programmed necrosis
and autophagy.
As has been described for programmed necrosis, the pMHC-
induced CTL death involves the generation of ROS and depolar-
ization of mitochondrial membranes, which results in lethal mito-
chondrial dysfunction (32). In agreement with this, we found that
cyclosporin A, which putatively protects mitochondria by in-
hibiting permeability transition pore opening (40), prevents
pMHC-induced death of CTL (Fig. 7). However, it should be
noted that cyclosporin A also inhibits the protein phosphatase
calcineurin, which is involved in T cell signaling (41). A likely
scenario is that pMHC complexes containing short linkers (i.e.,
DapS dimer and DapS/P10 octamer) strongly activate CTL, and
therefore trigger high mitochondrial activity to meet the in-
creased demand of ATP (42). The observed production of ROS
thus probably results from interaction of electrons shed from
the respiratory chain with molecular oxygen, resulting in for-
mation of superoxide and by catalytic conversion in other ROS
(32, 42). The production of ROS and depolarization of mito-
chondrial membranes and the ensuing mitochondrial dysfunc-
tion are linked, as seen by the inhibition of pMHC-induced cell
death by antioxidants, in particular of MitoQ, which selectively
targets mitochondria (35).
The failure of the long pMHC complexes to elicit death of CTL
thus is best explained by their inability to activate CTL. The short
DapS, but not the long P30 dimer induced strong calcium mobi-
lization and phosphorylation of signaling molecules (e.g., Lck,
linker for activation of T cells (LAT), ZAP-70, and phospholipase
C1) (21). Similar differences were observed for the long and short
tetramers (our unpublished results). The most plausible explana-
tion for this is that the short pMHC oligomers induce strong co-
cross-linking of TCR and CD8, resulting in vigorous activation of
Src kinases, namely, CD8-associated Lck, which is the initial crit-
ical event in pMHC-driven CTL activation (10, 12, 29). In accor-
dance with this is the finding that monomeric and pMHC com-
plexes containing long rigid spacers elicit no or scant CTL
activation and CTL death (Figs. 3, 4, and 10; Ref. 21 and our
unpublished data). Also, inhibition of CTL activation by different
agents impaired pMHC-mediated CTL death (Table II).
Other factors that determine the susceptibility of T cells to un-
dergo pMHC activation-dependent autonomous death is the ex-
pression of anti- and proapoptotic Bcl-2 family members such as
Bcl-2, Bcl-xL, Bax, Bim, and Bcl-2/adenovirus E1B 19-kDa pro-
tein-interacting protein 3 (BNIP3) (6, 43). As assessed by Western
blotting, both S14 TCR and effector T1 T cells expressed high
levels of the latter two molecules (our unpublished results). Al-
though Bcl-2 prevents T cell death, Bim and BNIP3 promote it,
namely, by acting at the mitochondrial outer membrane (6, 43).
Bim, but not BNIP3, was reported to induce the activation of ef-
fector caspases and cytochrome c release from mitochondria (5,
44, 45). The relative expression levels of Bcl-2 anti- and proapop-
totic family members thus determine the susceptibility of T cells to
undergo mitochondrial dysfunction-mediated cell death. Because
FIGURE 8. DapS dimer-induced S14 CTL death is not accompanied by
cytochrome c release and DNA fragmentation. A, S14 CTL were incubated
at 37°C for the indicated periods of time with Kd-PbCS(ABA)P255A DapS
dimer (12.5 nM), and DNA fragmentation was assessed by flow cytometry
upon labeling of DNA fragments (TUNEL) (f). Alternatively, cells were
stained with annexin V and analyzed by flow cytometry (u). Mean values
and SD were calculated from two independent experiments. B, Untreated
S14 CTL (lane 1) or cells incubated at 37°C for 30 min with monomer (200
nM) (lane 2), DapS dimer (12.5 nM) (lane 3), or P30 dimer (12.5 nM)
(lane 4) were lysed on ice with digitonin. Detergent-soluble (Cytosol) and
-insoluble membrane fractions (Membranes) were resolved on SDS-PAGE
and Western blotted with Abs specific for cytochrome c, COX IV, and
actin, respectively. One representative of two experiments is shown.
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naïve and memory T cells typically express higher levels of anti-
apoptotic molecules, namely, Bcl-2, than activated effector CTL,
this most likely explains why the latter are more susceptible to
pMHC-induced death (6, 46).
Although it is established that expression of Bcl-2 and its family
members in T cells is dependent on their differentiation and state
of activation (46), it seems also to be a clonal property. In a cur-
rently ongoing study, we have found that HLA-A2-restricted
Melan A-specific CTL clones obtained by FACS cloning with re-
versible tetramers, exhibit different susceptibility to undergo
pMHC activation-dependent death. It is therefore conceivable that,
upon FACS sorting or cloning using conventional pMHC multim-
ers, certain CTL are selectively lost. This is intriguing in view of
the observation that Melan A-specific CTL that were cloned by
using CD8 binding-deficient pMHC multimers, more effectively
killed melanoma cells when compared with CTL obtained by clon-
ing using conventional multimers (47). Also, CTL that were ob-
tained by FACS cloning using reversible multimers exhibited su-
perior lytic properties than CTL isolated by means of conventional
multimers (11). Both the CD8 binding-deficient and the reversible
pMHC multimers have greatly reduced ability to activate Ag-spe-
cific CTL (11, 48). In view of our finding that pMHC-provoked
death of CTL is activation dependent (Fig. 3 and Table I), this
probably explains why these reagents allow isolation of bona
fide CTL.
In the present study, we show for the first time that the soluble
pMHC complexes’ induced death of CTL depends on their ability
to activate the CTL (Fig. 3; Table I). The key determinant for this
is the distance between individual pMHC units and to a much
lesser extent their valence, which largely determines their ability to
activate CTL. This is illustrated by the dimeric pMHC complexes.
Dimers containing short linkers strongly trigger calcium mobili-
zation, diverse phosphorylation events, and CTL death, whereas
dimers containing long linkers do not (Figs. 2–4 and 10; Ref. 21).
The same was true for tetramers: those containing the short PEO
linker (25 Å) induced strong calcium mobilization and CTL death,
whereas those containing the long P24 linker (88 Å) were inactive
(Figs. 3 and 10, and our unpublished results). Thus, in terms of
practical applications, soluble pMHC complexes containing short
linkers can be used to eradicate Ag-specific CTL. This may be of
interest in autoimmune disorders like diabetes type I, for which a
growing number of epitopes of CTL involved in the disease in-
duction are identified (49). In contrast, soluble complexes contain-
ing long linkers should be used when the aim is to isolate bona fide
CTL. Because such complexes are inexpensive and simple to pre-
pare, they therefore provide an attractive alternative to the revers-
ible pMHC complexes.
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